Adjuvant immunotherapy in renal cell carcinoma: a systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2023 at "BJU International"
DOI: 10.1111/bju.15981
Abstract: To synthesise available data regarding the disease‐free survival (DFS) benefit of adjuvant immune checkpoint inhibitors (ICIs) for patients with renal cell carcinoma (RCC) and evaluate the overall safety profile of ICIs in this setting. read more here.
Keywords: adjuvant immunotherapy; cell carcinoma; renal cell; immunotherapy renal ... See more keywords